Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides
NCT00108511 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2009-01-21
Summary
The purpose of this study is to examine the role of glycosylphosphatidylinositol-specific phospholipase D (GPI-PLD) in triglyceride metabolism.
Conditions
- Hypertriglyceridemia
Interventions
- DRUG
-
Gemfibrozil
Sponsors & Collaborators
-
US Department of Veterans Affairs
lead FED
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 19 Years
- Max Age
- 74 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-10-31
- Completion
- 2007-09-30
Countries
- United States
Study Locations
More Related Trials
-
Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)
NCT01047501 ·Status: COMPLETED ·Phase: PHASE3
-
A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins
NCT02634151 ·Status: COMPLETED ·Phase: PHASE2
-
Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy
NCT00079859 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function
NCT03001817 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients on Stable Statin Therapy
NCT02571257 ·Status: COMPLETED ·Phase: PHASE2
-
Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED)
NCT00726856 ·Status: COMPLETED
-
Differential Metabolic Effects of Fenofibrate and Fatty Acid
NCT01003847 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia
NCT01912560 ·Status: COMPLETED ·Phase: PHASE2
-
Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy
NCT03874260 ·Status: UNKNOWN ·Phase: PHASE4
-
Lipid Biomarker Study in Men With Dyslipidemia After Simvastatin Treatment (Study MK-0000-140)(COMPLETED)
NCT00935259 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia
NCT05852431 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins
NCT01859455 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating Potential Interaction Between SAM-531 And Gemfibrozil When Co-Administered
NCT00966966 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects
NCT01720537 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C
NCT04998981 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)
NCT00093899 ·Status: COMPLETED ·Phase: PHASE3
-
A Drug Interaction Study Between Simvastatin and GSK376501
NCT00605449 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2)
NCT03361501 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL
NCT01047683 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Evacetrapib in Healthy Participants
NCT01736254 ·Status: COMPLETED ·Phase: PHASE1
-
A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease
NCT01674712 ·Status: COMPLETED ·Phase: PHASE3
-
Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)
NCT00409773 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Evolocumab Versus Placebo Added to Standard Lipid-lowering Therapy on Fasting and Post Fat Load Lipids in Patients With Familial Dysbetalipoproteinemia
NCT03811223 ·Status: UNKNOWN ·Phase: PHASE4
-
Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome
NCT02015988 ·Status: UNKNOWN ·Phase: PHASE4
-
The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-Cholesterol
NCT00283335 ·Status: COMPLETED ·Phase: PHASE3